Primary systemic vasculitides as the bridge in immune-mediated disorders: small vessels for autoimmunity, medium vessels for autoinflammation

Vasculitides have been classically considered to be mostly of autoimmune origin, but the role of the innate immune system is being increasingly recognized among primary systemic vasculitides. For example, Behçet’s syndrome (BS) shares more common features with autoinflammatory disorders (AIDs) than...

Full description

Bibliographic Details
Main Authors: Tiago Borges, Ana Rita Gomes, João Santos, Sérgio Silva
Format: Article
Language:English
Published: Sociedade Portuguesa de Reumatologia 2021-01-01
Series:Acta Reumatológica Portuguesa
Subjects:
Online Access:http://www.actareumatologica.com/files/article/1350_primary_systemic_vasculitides_as_the_bridge_in_immune_mediated_disorders_small_vessels_for_autoimmunity_medium_vessels_for_autoinflammation_file.pdf
id doaj-4fac8cdc68d44fa9aaf2123fa48d1b3e
record_format Article
spelling doaj-4fac8cdc68d44fa9aaf2123fa48d1b3e2021-04-09T12:01:33ZengSociedade Portuguesa de ReumatologiaActa Reumatológica Portuguesa0303-464X2021-01-01202115868AR200303Primary systemic vasculitides as the bridge in immune-mediated disorders: small vessels for autoimmunity, medium vessels for autoinflammationTiago Borges0Ana Rita Gomes1João Santos2Sérgio Silva3Department of Internal Medicine, Trofa Saúde Hospital Privado de Gaia, Vila Nova de Gaia, PortugalDepartment of Internal Medicine, Hospital de Vila Franca de Xira, Vila Franca de Xira, PortugalACES Baixo Tâmega, UCSP Resende, Resende, PortugalDepartment of Internal Medicine, Trofa Saúde Hospital Privado de Gaia, Vila Nova de Gaia, PortugalVasculitides have been classically considered to be mostly of autoimmune origin, but the role of the innate immune system is being increasingly recognized among primary systemic vasculitides. For example, Behçet’s syndrome (BS) shares more common features with autoinflammatory disorders (AIDs) than autoimmune diseases (ADs) and has recently been considered to be a polygenic AID by several authors, while others have classified it as a “mixed-pattern” disorder. This review aims to make a balance between autoinflammatory and autoimmune features of primary systemic vasculitides, including sex prevalence, association and/or familial aggregation with others AIDs or ADs, with human leukocyte antigen (HLA) system and/or disease-specific autoantibodies, type of cellular infiltration (neutrophilic or lymphocytic), clinical pattern (episodic or progressive), size of involved joints when articular involvement occurs, presence of lymphadenopathy or hypergammaglobulinemia, and therapeutic benefit of colchicine, IL-1 inhibitors and rituximab. Except for Henöch-Schonlein purpura, autoimmunity is usually predominant in small vessel vasculitides, where disease-specific autoantibodies are common. On the other hand, medium vessel and even variable vessel vasculitides such as BS often course with autoinflammatory features (e.g. increased levels of IL-1, neutrophilic infiltration) are often more obvious than those typical of autoimmunity. Therefore, it is possible that disorders like polyarteritis nodosa or Kawasaki disease may be considered as “mixed-pattern” diseases in the future. Finally, both the innate and adaptive immune systems can have significant roles in large vessel vasculitis.http://www.actareumatologica.com/files/article/1350_primary_systemic_vasculitides_as_the_bridge_in_immune_mediated_disorders_small_vessels_for_autoimmunity_medium_vessels_for_autoinflammation_file.pdfautoimmunityautoinflammatory disordersinnate immunityvasculitissystemic vasculitis
collection DOAJ
language English
format Article
sources DOAJ
author Tiago Borges
Ana Rita Gomes
João Santos
Sérgio Silva
spellingShingle Tiago Borges
Ana Rita Gomes
João Santos
Sérgio Silva
Primary systemic vasculitides as the bridge in immune-mediated disorders: small vessels for autoimmunity, medium vessels for autoinflammation
Acta Reumatológica Portuguesa
autoimmunity
autoinflammatory disorders
innate immunity
vasculitis
systemic vasculitis
author_facet Tiago Borges
Ana Rita Gomes
João Santos
Sérgio Silva
author_sort Tiago Borges
title Primary systemic vasculitides as the bridge in immune-mediated disorders: small vessels for autoimmunity, medium vessels for autoinflammation
title_short Primary systemic vasculitides as the bridge in immune-mediated disorders: small vessels for autoimmunity, medium vessels for autoinflammation
title_full Primary systemic vasculitides as the bridge in immune-mediated disorders: small vessels for autoimmunity, medium vessels for autoinflammation
title_fullStr Primary systemic vasculitides as the bridge in immune-mediated disorders: small vessels for autoimmunity, medium vessels for autoinflammation
title_full_unstemmed Primary systemic vasculitides as the bridge in immune-mediated disorders: small vessels for autoimmunity, medium vessels for autoinflammation
title_sort primary systemic vasculitides as the bridge in immune-mediated disorders: small vessels for autoimmunity, medium vessels for autoinflammation
publisher Sociedade Portuguesa de Reumatologia
series Acta Reumatológica Portuguesa
issn 0303-464X
publishDate 2021-01-01
description Vasculitides have been classically considered to be mostly of autoimmune origin, but the role of the innate immune system is being increasingly recognized among primary systemic vasculitides. For example, Behçet’s syndrome (BS) shares more common features with autoinflammatory disorders (AIDs) than autoimmune diseases (ADs) and has recently been considered to be a polygenic AID by several authors, while others have classified it as a “mixed-pattern” disorder. This review aims to make a balance between autoinflammatory and autoimmune features of primary systemic vasculitides, including sex prevalence, association and/or familial aggregation with others AIDs or ADs, with human leukocyte antigen (HLA) system and/or disease-specific autoantibodies, type of cellular infiltration (neutrophilic or lymphocytic), clinical pattern (episodic or progressive), size of involved joints when articular involvement occurs, presence of lymphadenopathy or hypergammaglobulinemia, and therapeutic benefit of colchicine, IL-1 inhibitors and rituximab. Except for Henöch-Schonlein purpura, autoimmunity is usually predominant in small vessel vasculitides, where disease-specific autoantibodies are common. On the other hand, medium vessel and even variable vessel vasculitides such as BS often course with autoinflammatory features (e.g. increased levels of IL-1, neutrophilic infiltration) are often more obvious than those typical of autoimmunity. Therefore, it is possible that disorders like polyarteritis nodosa or Kawasaki disease may be considered as “mixed-pattern” diseases in the future. Finally, both the innate and adaptive immune systems can have significant roles in large vessel vasculitis.
topic autoimmunity
autoinflammatory disorders
innate immunity
vasculitis
systemic vasculitis
url http://www.actareumatologica.com/files/article/1350_primary_systemic_vasculitides_as_the_bridge_in_immune_mediated_disorders_small_vessels_for_autoimmunity_medium_vessels_for_autoinflammation_file.pdf
work_keys_str_mv AT tiagoborges primarysystemicvasculitidesasthebridgeinimmunemediateddisorderssmallvesselsforautoimmunitymediumvesselsforautoinflammation
AT anaritagomes primarysystemicvasculitidesasthebridgeinimmunemediateddisorderssmallvesselsforautoimmunitymediumvesselsforautoinflammation
AT joaosantos primarysystemicvasculitidesasthebridgeinimmunemediateddisorderssmallvesselsforautoimmunitymediumvesselsforautoinflammation
AT sergiosilva primarysystemicvasculitidesasthebridgeinimmunemediateddisorderssmallvesselsforautoimmunitymediumvesselsforautoinflammation
_version_ 1721532634325057536